BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10728733)

  • 1. A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital.
    Watanabe H; Sato S; Kawakami K; Watanabe K; Oishi K; Rikitomi N; Ii T; Ikeda H; Sato A; Nagatake T
    Respirology; 2000 Mar; 5(1):59-64. PubMed ID: 10728733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
    Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.
    Block SL; Harrison CJ; Hedrick JA; Tyler RD; Smith RA; Keegan E; Chartrand SA
    Pediatr Infect Dis J; 1995 Sep; 14(9):751-9. PubMed ID: 8559623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of tedizolid phosphate (TR-701) in murine models of infection with penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.
    Choi S; Im W; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4713-7. PubMed ID: 22713339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C; Armengol R; Mir I; Lite J; Garau J
    Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.
    Rey LC; Wolf B; Moreira JL; Milatovic D; Verhoef J; Farhat CK
    Int J Antimicrob Agents; 2002 Aug; 20(2):86-92. PubMed ID: 12297356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on penicillin insusceptible/resistant Streptococcus pneumoniae in the elderly patients].
    Takahira K; Kataoka H; Masuda Y; Fukayama M; Hatakeya T; Ishihama Y; Inamatsu T
    Kansenshogaku Zasshi; 1997 Apr; 71(4):313-7. PubMed ID: 9164085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
    Tan TQ; Mason EO; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL
    Pediatrics; 1998 Dec; 102(6):1369-75. PubMed ID: 9832571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The utility of the Pneumonia PORT prediction rule for evaluating the severity of community-acquired pneumonia in Japan. The relationship between disease severity and drug-resistant Streptococcus pneumoniae].
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura M; Shimizu J
    Kansenshogaku Zasshi; 2002 Dec; 76(12):1003-9. PubMed ID: 12607346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin susceptibility of non-serotypeable Streptococcus pneumoniae from ophthalmic specimens.
    Kojima F; Nakagami Y; Takemori K; Iwatani Y; Fujimoto S
    Microb Drug Resist; 2006; 12(3):199-202. PubMed ID: 17002547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pneumococcal pneumonia: the case for penicillin G.
    Bryan CS
    Am J Med; 1999 Jul; 107(1A):63S-68S. PubMed ID: 10451011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical course of invasive pneumococcal disease caused by penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae in Thai children.
    Siripongpreeda N; Hattasingh W; Amornvipas P; Eampokalap B; Sakoolgnam S; Pancharoen C; Thisyakorn U
    J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S1-5. PubMed ID: 21298829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    Fukuoka T; Inoue H; Abe T; Ohya S
    Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
    Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.